Pérez BE, Rodríguez AR, Marín TMA, Ruíz MM, Bermúdez ML, Rodríguez NG

Language: Spanish
References: 20
Page:
PDF size: 74.75 Kb.

ABSTRACT

A descriptive and cross-sectional study was conducted in order to describe the clinical and epidemiological aspects of pleural effusion in patients seen in the Internal Medicine Department of the Arnaldo Milian Castro Provincial University Hospital in 2010. The universe was composed of 62 patients and the sample of 55 patients, as convenience sampling. The analysis of clinical histories was the key source of data. The clinical and epidemiological variables were defined, as well as the personal background, the etiological factors and therapeutics used. Percentage analysis and Chi square were used. White women predominated, aged 60-69 years, with smoking habit. Dyspnea and pain in the tip of the side were common symptoms. The right chest was the most affected. Small effusions were more frequent; pneumonia caused a greater number of effusions. The X-rays was the most common complementary test indicated at the time of admission. In the ward, after being admitted, the most commonly indicated test were complete blood count and glycemia. Third-generation cephalosporins were prescribed more frequently.

REFERENCES

1. Villena Garrido V, Ferrer Sancho J, Hernández Blasco L. Diagnosis and treatment of pleural effusion. Arch Bronconeumonol. 2006;42(7):349-72 .

2. Bautista AJ. Diagnóstico de derrame pleural en adultos. Hospital Juan Bautista. Rosario, Santa Fe, Argentina. Rev Méd Rosario. 2008;74:122-34.

3. Porcel JM, Chorda J, Cao G. Comparing serum and pleural fluid pro-brain natriuretic peptide (NTproBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light´s criteria. Respirology. 2007;12:654-9.

4. Broaddus VC, Light RW. Pleural Effusion. In: Mason RJ, Broaddus VC, Martin TR, editors. Textbook of Respiratory Medicine. 5th ed. Philadelphia: Saunders Elsevier; 2010. p. 1719–63.

5. Páez I, Pino P, Rodríguez J y cols. Derrame pleural: marcadores bioquímicos en el enfoque diagnóstico. Rev Cubana Med. 1998;37(2):93-9.

6. Kalomenidis I, Rodriguez M, Barnette R. Patients with bilateral pleural effusion: are the findings the same in each fluid. Chest. 2003 Jul;124(1):167-76.

7. Villena A, López Encuentra J, Echave Sustaeta C, Álvarez Martínez A, Martín Escribano P. Estudio prospectivo de 1.000 pacientes consecutivos con derrame pleural. Etiología del derrame y características de los pacientes Arch Bronconeumol [Internet]. 2002 [citado 20 May 2011];38(1):21-6. Disponible en: www.elsevier.es/.../archivos-bronconeumologia.../estudio-prospectivo-1000- pacientes-consecutivos-derrame-pleural-13025507-originales-2002

8. Arciniegas Quiroga W. Eficacia de la biopsia pleural con aguja en el diagnóstico de la enfermedad pleural. Rev Med Risaralda. 2003;9(1):1-7.

9. Soriano Sánchez T. Estudio del engrosamiento pleural residual en los derrames pleurales paraneumónicos y empiemas y su asociación con los marcadores de actividad neutrofílica. [tesis]. Trabajo para optar por el título de Doctor en Medicina. Bellaterra: Universidad Autónoma de Barcelona; 2007.

10. Santotoribio Camacho JD. Diagnóstico y tratamiento de los derrames pleurales paraneumónicos y empiemas según la presión parcial de dióxido de carbono de líquido pleural. [tesis]. Trabajo para optar por el título de Doctor en Medicina y Cirugía. Andalucia, España: Universidad de Sevilla; 2009.

11. Marcel M, Zrustová M, Stasny B, Light RW. The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest. 1993 Nov;104(5):1486-9.

12. Páez S, Roa JH. Derrame pleural. En: Asociación Colombiana de Medicina Interna. Manual de Urgencias en Medicina Interna. [Internet]. Colombia: Acta Médica Colombiana; 1994 [actualizado 1 Ago 2007; citado 24 Nov 2009]. Disponible en: http://www.aibarra.org/Guias/3-19.htm

13. Davies RJ, Gleeson FV. Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. Introduction to the methods used in the generation of the British Thoracic Society guidelines for the management of pleural diseases. Thorax. 2003 May;58 Suppl 2:8-17.

14. Zuckerman DA, Reed MF, Howington JA, Moulton JS. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions. J Vasc Interv Radiol. 2009;20(8):1066–69.

15. Rajas Naranjo O. Derrame pleural [Internet]. Madrid: Saludalia Interactiva; 2003 [actualizado 12 Sep 2011; citado 12 Ene 2012]. Disponible en: www.saludalia.com/enfermedades/derrame-pleural

16. Paz F, Céspedes F, Cuevas M, Lecorre N, Navarro C, Sánchez I. Derrame pleural y empiema complicado en niños. Evolución y factores pronósticos. Rev Méd Chile [Internet]. 2001 [citado 25 Mar 2009];129(11): [aprox. 7p.]. Disponible en: www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034

17. Yu H. Management of Pleural Effusion, Empyema, and Lung Abscess. Semin Intervent Radiol. 2011 Mar;28(1):75–86.

18. Bielsa S, Panades WJ, Egido R, Rue W, Salud A, Matías-Guiu, et al. Rentabilidad del estudio citologico del liquido pleural en el derrame maligno. An Med Interna (Madrid). 2008 Apr;25(4):173-7.

19. Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med. 2009;15(4):380–7.

20. Tsuji S. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion. Br J Cancer. 2010 Aug 10;103(4):517–23.